HiBiT®, HaloTag®, NanoLuc®, and NanoBiT® tools now available for your cells.
Products

Products

Human iPSC Line (Episomal, MSC)

Footprint-free iPSC generated by episomal plasmids

Catalog Number iPS12
Unit 5x105 cells/vial
Shipping Condition Dry Ice - Overnight Shipping
Volume
5x105 cells/vial

Have questions? Contact us

Cat no. iPS12
Price $1558.00
In stock
Add to Cart Request bulk or custom quote

Highlights

Footprint-free human iPS12 cell lines generated by episomal plasmids are ideally suited for various research purpose including 1) differentiating various somatic cells or organoid models for phenotypic and target-based compound screening, 2) establishing genetically modified disease model through CRISPR/Cas9 editing, and 3) generating functional cells/tissues as regenerative biology initiatives. iPS12 has several features such as:

  • Low passage and long-term viability
  • Off the shelf - simple thaw the cells and plate them onto serum-free, feeder-free culture
  • Transgene- and Virus-free (episomal)
  • Homogeneity– Originated from a single iPSC clone
Description
Specifications
Documents
Publications

Footprint-free human iPS (induced pluripotent stem) cell line was derived from human mesenchymal stromal cells (MSCs) by ectopic expression of OCT4, SOX2, KLF4, and L-MYC genes using episomal plasmids.

Product Name Human iPSC Line (Episomal, MSC)
Shipping Condition

Dry Ice - Overnight Shipping

Storage and Stability

Store in vapor phase of liquid nitrogen immediately upon receipt. This product is stable for 6 months when stored as directed.

Quality Control

Human iPS cells were grown in feeder free conditions with mTeSR1 medium. Each lot of human iPS cells is tested for growth and viability following recovery from cryopreservation. In addition, each lot is tested for expression of TRA-1-60 and Oct4, as well as the activity of alkaline phosphatase.

Restricted Use

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

  • Gao Q. et al., Personalized bone organoid using iPSC-derived cells for clinically relevant applications. Res Sq (2024).
  • Yang D. et al., A Novel Humanized Immune Stroma PDX Cancer Model for Therapeutic Studies bioRxiv (2023).

Have Questions?

If you don't see the product you're looking for, please don't hesitate to CONTACT US. Our dedicated team of scientists will provide you our best solutions for your desired results.

Contact Our Experts